The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Thalassemia Major: Comprehensive Care

Beta-thalassemia major management with transfusion, chelation and curative options

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Thalassemia Major: Comprehensive Care?

Beta-thalassemia major results from homozygous or compound heterozygous mutations in the beta-globin gene leading to severe anemia presenting in early childhood.

Ineffective erythropoiesis, hemolysis and chronic anemia drive bone marrow expansion, extramedullary hematopoiesis and growth retardation.

Diagnosis is confirmed by hemoglobin electrophoresis or HPLC showing absent or markedly reduced HbA, elevated HbF and variable HbA2.

Genetic testing identifies specific mutations and guides family screening and prenatal diagnosis.

Severity is influenced by mutation type, alpha-globin gene number, HbF persistence and modifier genes.

Symptoms

Severe anemia presenting between 6 and 24 months of age with pallor, fatigue and failure to thrive.
Skeletal changes including frontal bossing, maxillary hyperplasia and cortical thinning of long bones.
Hepatosplenomegaly from extramedullary hematopoiesis and chronic hemolysis.
Growth retardation, delayed puberty and endocrine dysfunction (hypothyroidism, hypogonadism, diabetes) in untreated patients.
Cardiac complications include iron overload cardiomyopathy, arrhythmias and heart failure as leading cause of mortality.

Risk Factors

Mediterranean, Middle Eastern, South Asian, Southeast Asian and African ancestry.
Consanguineous marriage substantially increases risk in carrier populations.
Lack of premarital or prenatal screening in high-prevalence regions.
Limited access to safe transfusions, chelation and specialist care worsens outcomes.
Coexisting alpha-thalassemia, hemoglobin variants or hereditary persistence of fetal hemoglobin modifies severity.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Pallor, failure to thrive and severe anemia in infants requires hematology referral.
  • Family history of thalassemia or carrier status warrants genetic counseling and screening.
  • Existing patients with new fevers, bone pain, dark urine or transfusion reactions need prompt evaluation.
  • Symptoms of cardiac dysfunction such as dyspnea, palpitations, edema or syncope require urgent assessment.
  • Endocrine symptoms including delayed puberty, polyuria, fatigue or weight changes need specialist review.

Treatment Methods

01
Regular red cell transfusions every 2 to 4 weeks maintain hemoglobin between 9.5 and 10.5 g/dL to suppress ineffective erythropoiesis.
02
Iron chelation with deferasirox, deferoxamine or deferiprone is essential to prevent and treat transfusion-related iron overload.
03
Splenectomy may be considered for hypersplenism with high transfusion requirements but increases infection risk.
04
Allogeneic stem cell transplantation from matched sibling donors offers cure in selected children.
05
Gene therapy with autologous lentiviral vector products (betibeglogene autotemcel) and CRISPR-based therapy (exagamglogene autotemcel) provide transformative options; comprehensive care includes endocrine management, cardiac monitoring, vaccinations, fertility preservation and psychosocial support.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.